| Name | Title | Contact Details |
|---|
Caladrius is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company`s platform technology leverages these cells to enable the body`s natural repair mechanisms using formulations unique to each medical indication.
Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders.
Sustainable Bioproducts has developed a breakthrough protein production platform for a variety of consumer and industrial applications.
AlgiKnit is a collective of designers and scientists who work across disciplines to create new material possibilities. Were creating sustainable, algae-derived, biodegradable yarns and textiles to remediate harmful cycles of fast fashion. Bui...
Xenotope Diagnostics is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.